| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.05 | 0.4 |